nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CYP1A2—Omeprazole—Barrett's esophagus	0.149	0.533	CbGbCtD
Alitretinoin—ABCB1—Omeprazole—Barrett's esophagus	0.13	0.466	CbGbCtD
Alitretinoin—Acitretin—CYP26A1—Barrett's esophagus	0.0106	0.588	CrCbGaD
Alitretinoin—CRABP1—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.00928	0.0363	CbGpPWpGaD
Alitretinoin—CRABP2—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.00928	0.0363	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00756	0.0295	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00756	0.0295	CbGpPWpGaD
Alitretinoin—Vitamin A—CYP26A1—Barrett's esophagus	0.00744	0.412	CrCbGaD
Alitretinoin—RARG—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00692	0.027	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00678	0.0265	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00678	0.0265	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.0065	0.0254	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.0065	0.0254	CbGpPWpGaD
Alitretinoin—RXRG—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00633	0.0247	CbGpPWpGaD
Alitretinoin—RARG—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.00627	0.0245	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00621	0.0242	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00595	0.0232	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00595	0.0232	CbGpPWpGaD
Alitretinoin—RXRG—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.00573	0.0224	CbGpPWpGaD
Alitretinoin—RARB—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.00562	0.022	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00547	0.0214	CbGpPWpGaD
Alitretinoin—RXRB—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.00539	0.0211	CbGpPWpGaD
Alitretinoin—RARA—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.00539	0.0211	CbGpPWpGaD
Alitretinoin—RXRG—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.005	0.0195	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.0049	0.0192	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.0047	0.0184	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.0047	0.0184	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptors—NR1I2—Barrett's esophagus	0.0031	0.0121	CbGpPWpGaD
Alitretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—Barrett's esophagus	0.00308	0.0121	CbGpPWpGaD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—Barrett's esophagus	0.00282	0.011	CbGpPWpGaD
Alitretinoin—RXRA—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.00281	0.011	CbGpPWpGaD
Alitretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—Barrett's esophagus	0.00277	0.0108	CbGpPWpGaD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—Barrett's esophagus	0.00265	0.0104	CbGpPWpGaD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—Barrett's esophagus	0.00265	0.0104	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00249	0.00972	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00245	0.00957	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—CYP26A1—Barrett's esophagus	0.00237	0.00924	CbGpPWpGaD
Alitretinoin—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00236	0.00921	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptors—PPARG—Barrett's esophagus	0.00228	0.0089	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00223	0.00872	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—CYP26A1—Barrett's esophagus	0.00222	0.00869	CbGpPWpGaD
Alitretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00215	0.00841	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00214	0.00836	CbGpPWpGaD
Alitretinoin—RXRG—Nuclear Receptors—PPARG—Barrett's esophagus	0.00208	0.00814	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptors—PPARG—Barrett's esophagus	0.00204	0.00798	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptors—PPARG—Barrett's esophagus	0.00196	0.00765	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptors—PPARG—Barrett's esophagus	0.00196	0.00765	CbGpPWpGaD
Alitretinoin—Hepatocellular injury—Esomeprazole—Barrett's esophagus	0.00185	0.00413	CcSEcCtD
Alitretinoin—Phosphatase alkaline increased—Omeprazole—Barrett's esophagus	0.00185	0.00413	CcSEcCtD
Alitretinoin—Injection site reaction—Omeprazole—Barrett's esophagus	0.00184	0.0041	CcSEcCtD
Alitretinoin—Injection site reaction—Esomeprazole—Barrett's esophagus	0.00184	0.0041	CcSEcCtD
Alitretinoin—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.0018	0.00403	CcSEcCtD
Alitretinoin—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.0018	0.00403	CcSEcCtD
Alitretinoin—RARG—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.0018	0.00703	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—BMP4—Barrett's esophagus	0.00179	0.007	CbGpPWpGaD
Alitretinoin—Cystitis—Esomeprazole—Barrett's esophagus	0.00178	0.00399	CcSEcCtD
Alitretinoin—Cystitis—Omeprazole—Barrett's esophagus	0.00178	0.00399	CcSEcCtD
Alitretinoin—Candida infection—Omeprazole—Barrett's esophagus	0.00176	0.00394	CcSEcCtD
Alitretinoin—Candida infection—Esomeprazole—Barrett's esophagus	0.00176	0.00394	CcSEcCtD
Alitretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00174	0.00682	CbGpPWpGaD
Alitretinoin—Dry eye—Omeprazole—Barrett's esophagus	0.00171	0.00381	CcSEcCtD
Alitretinoin—Dry eye—Esomeprazole—Barrett's esophagus	0.00171	0.00381	CcSEcCtD
Alitretinoin—Oesophagitis—Esomeprazole—Barrett's esophagus	0.00169	0.00377	CcSEcCtD
Alitretinoin—Oesophagitis—Omeprazole—Barrett's esophagus	0.00169	0.00377	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—BMP4—Barrett's esophagus	0.00169	0.00659	CbGpPWpGaD
Alitretinoin—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.00168	0.00375	CcSEcCtD
Alitretinoin—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.00168	0.00375	CcSEcCtD
Alitretinoin—Bladder pain—Esomeprazole—Barrett's esophagus	0.00167	0.00373	CcSEcCtD
Alitretinoin—Mouth ulceration—Omeprazole—Barrett's esophagus	0.00167	0.00373	CcSEcCtD
Alitretinoin—Bladder pain—Omeprazole—Barrett's esophagus	0.00167	0.00373	CcSEcCtD
Alitretinoin—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.00167	0.00373	CcSEcCtD
Alitretinoin—Lightheadedness—Omeprazole—Barrett's esophagus	0.00165	0.00369	CcSEcCtD
Alitretinoin—Lightheadedness—Esomeprazole—Barrett's esophagus	0.00165	0.00369	CcSEcCtD
Alitretinoin—RXRG—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00165	0.00643	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00161	0.00631	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—PPARG—Barrett's esophagus	0.00158	0.00617	CbGpPWpGaD
Alitretinoin—Ear pain—Esomeprazole—Barrett's esophagus	0.00157	0.00351	CcSEcCtD
Alitretinoin—Ear pain—Omeprazole—Barrett's esophagus	0.00157	0.00351	CcSEcCtD
Alitretinoin—Lymphadenopathy—Esomeprazole—Barrett's esophagus	0.00157	0.00351	CcSEcCtD
Alitretinoin—Lymphadenopathy—Omeprazole—Barrett's esophagus	0.00157	0.00351	CcSEcCtD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00155	0.00606	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00155	0.00606	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00155	0.00605	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00155	0.00605	CbGpPWpGaD
Alitretinoin—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00154	0.00345	CcSEcCtD
Alitretinoin—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00154	0.00345	CcSEcCtD
Alitretinoin—Photosensitivity—Omeprazole—Barrett's esophagus	0.00153	0.00341	CcSEcCtD
Alitretinoin—Photosensitivity—Esomeprazole—Barrett's esophagus	0.00153	0.00341	CcSEcCtD
Alitretinoin—Swelling—Esomeprazole—Barrett's esophagus	0.00152	0.0034	CcSEcCtD
Alitretinoin—Swelling—Omeprazole—Barrett's esophagus	0.00152	0.0034	CcSEcCtD
Alitretinoin—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00141	0.00316	CcSEcCtD
Alitretinoin—Visual disturbance—Omeprazole—Barrett's esophagus	0.00141	0.00316	CcSEcCtD
Alitretinoin—Renal impairment—Esomeprazole—Barrett's esophagus	0.00141	0.00315	CcSEcCtD
Alitretinoin—Renal impairment—Omeprazole—Barrett's esophagus	0.00141	0.00315	CcSEcCtD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—Barrett's esophagus	0.00138	0.0054	CbGpPWpGaD
Alitretinoin—Arthritis—Esomeprazole—Barrett's esophagus	0.00138	0.00308	CcSEcCtD
Alitretinoin—Arthritis—Omeprazole—Barrett's esophagus	0.00138	0.00308	CcSEcCtD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00135	0.00529	CbGpPWpGaD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00135	0.00529	CbGpPWpGaD
Alitretinoin—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00134	0.003	CcSEcCtD
Alitretinoin—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00134	0.003	CcSEcCtD
Alitretinoin—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00134	0.003	CcSEcCtD
Alitretinoin—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00134	0.003	CcSEcCtD
Alitretinoin—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00134	0.003	CcSEcCtD
Alitretinoin—Pain in extremity—Omeprazole—Barrett's esophagus	0.00134	0.003	CcSEcCtD
Alitretinoin—Face oedema—Omeprazole—Barrett's esophagus	0.00129	0.00289	CcSEcCtD
Alitretinoin—Face oedema—Esomeprazole—Barrett's esophagus	0.00129	0.00289	CcSEcCtD
Alitretinoin—Irritability—Esomeprazole—Barrett's esophagus	0.00128	0.00286	CcSEcCtD
Alitretinoin—Irritability—Omeprazole—Barrett's esophagus	0.00128	0.00286	CcSEcCtD
Alitretinoin—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.00126	0.00281	CcSEcCtD
Alitretinoin—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.00126	0.00281	CcSEcCtD
Alitretinoin—Dry skin—Esomeprazole—Barrett's esophagus	0.00123	0.00275	CcSEcCtD
Alitretinoin—Dry skin—Omeprazole—Barrett's esophagus	0.00123	0.00275	CcSEcCtD
Alitretinoin—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00121	0.0027	CcSEcCtD
Alitretinoin—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00121	0.0027	CcSEcCtD
Alitretinoin—Gastritis—Omeprazole—Barrett's esophagus	0.00119	0.00265	CcSEcCtD
Alitretinoin—Gastritis—Esomeprazole—Barrett's esophagus	0.00119	0.00265	CcSEcCtD
Alitretinoin—Abdominal distension—Omeprazole—Barrett's esophagus	0.00117	0.00261	CcSEcCtD
Alitretinoin—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00117	0.00261	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—CYP26A1—Barrett's esophagus	0.00116	0.00453	CbGpPWpGaD
Alitretinoin—Dysphagia—Esomeprazole—Barrett's esophagus	0.00116	0.00259	CcSEcCtD
Alitretinoin—Asthma—Esomeprazole—Barrett's esophagus	0.00116	0.00259	CcSEcCtD
Alitretinoin—Dysphagia—Omeprazole—Barrett's esophagus	0.00116	0.00259	CcSEcCtD
Alitretinoin—Asthma—Omeprazole—Barrett's esophagus	0.00116	0.00259	CcSEcCtD
Alitretinoin—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00114	0.00255	CcSEcCtD
Alitretinoin—Bronchospasm—Omeprazole—Barrett's esophagus	0.00114	0.00255	CcSEcCtD
Alitretinoin—Pancreatitis—Omeprazole—Barrett's esophagus	0.00114	0.00254	CcSEcCtD
Alitretinoin—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00114	0.00254	CcSEcCtD
Alitretinoin—Sweating increased—Esomeprazole—Barrett's esophagus	0.00113	0.00252	CcSEcCtD
Alitretinoin—Sweating increased—Omeprazole—Barrett's esophagus	0.00113	0.00252	CcSEcCtD
Alitretinoin—Dysuria—Omeprazole—Barrett's esophagus	0.00108	0.00242	CcSEcCtD
Alitretinoin—Neutropenia—Esomeprazole—Barrett's esophagus	0.00108	0.00242	CcSEcCtD
Alitretinoin—Dysuria—Esomeprazole—Barrett's esophagus	0.00108	0.00242	CcSEcCtD
Alitretinoin—Neutropenia—Omeprazole—Barrett's esophagus	0.00108	0.00242	CcSEcCtD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00108	0.00422	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00108	0.00422	CbGpPWpGaD
Alitretinoin—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00108	0.00241	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00108	0.00241	CcSEcCtD
Alitretinoin—Pollakiuria—Omeprazole—Barrett's esophagus	0.00107	0.00239	CcSEcCtD
Alitretinoin—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00107	0.00239	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.00106	0.00236	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.00106	0.00236	CcSEcCtD
Alitretinoin—Weight increased—Omeprazole—Barrett's esophagus	0.00105	0.00236	CcSEcCtD
Alitretinoin—Weight increased—Esomeprazole—Barrett's esophagus	0.00105	0.00236	CcSEcCtD
Alitretinoin—Weight decreased—Omeprazole—Barrett's esophagus	0.00105	0.00234	CcSEcCtD
Alitretinoin—Weight decreased—Esomeprazole—Barrett's esophagus	0.00105	0.00234	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00105	0.00409	CbGpPWpGaD
Alitretinoin—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00103	0.00231	CcSEcCtD
Alitretinoin—Infestation—Omeprazole—Barrett's esophagus	0.00103	0.00231	CcSEcCtD
Alitretinoin—Infestation—Esomeprazole—Barrett's esophagus	0.00103	0.00231	CcSEcCtD
Alitretinoin—Infestation NOS—Omeprazole—Barrett's esophagus	0.00103	0.00231	CcSEcCtD
Alitretinoin—Depression—Esomeprazole—Barrett's esophagus	0.00103	0.0023	CcSEcCtD
Alitretinoin—Depression—Omeprazole—Barrett's esophagus	0.00103	0.0023	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.00102	0.00229	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.00102	0.00229	CcSEcCtD
Alitretinoin—RXRA—Nuclear Receptors—PPARG—Barrett's esophagus	0.00102	0.00399	CbGpPWpGaD
Alitretinoin—Renal failure—Omeprazole—Barrett's esophagus	0.00102	0.00227	CcSEcCtD
Alitretinoin—Renal failure—Esomeprazole—Barrett's esophagus	0.00102	0.00227	CcSEcCtD
Alitretinoin—Stomatitis—Omeprazole—Barrett's esophagus	0.00101	0.00225	CcSEcCtD
Alitretinoin—Stomatitis—Esomeprazole—Barrett's esophagus	0.00101	0.00225	CcSEcCtD
Alitretinoin—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.001	0.00225	CcSEcCtD
Alitretinoin—Conjunctivitis—Omeprazole—Barrett's esophagus	0.001	0.00225	CcSEcCtD
Alitretinoin—Urinary tract infection—Omeprazole—Barrett's esophagus	0.001	0.00225	CcSEcCtD
Alitretinoin—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.001	0.00225	CcSEcCtD
Alitretinoin—Haematuria—Esomeprazole—Barrett's esophagus	0.000985	0.0022	CcSEcCtD
Alitretinoin—Haematuria—Omeprazole—Barrett's esophagus	0.000985	0.0022	CcSEcCtD
Alitretinoin—Epistaxis—Esomeprazole—Barrett's esophagus	0.000974	0.00218	CcSEcCtD
Alitretinoin—Epistaxis—Omeprazole—Barrett's esophagus	0.000974	0.00218	CcSEcCtD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.000971	0.00379	CbGpPWpGaD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.000971	0.00379	CbGpPWpGaD
Alitretinoin—Sinusitis—Omeprazole—Barrett's esophagus	0.000969	0.00217	CcSEcCtD
Alitretinoin—Sinusitis—Esomeprazole—Barrett's esophagus	0.000969	0.00217	CcSEcCtD
Alitretinoin—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000964	0.00216	CcSEcCtD
Alitretinoin—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000964	0.00216	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000944	0.00369	CbGpPWpGaD
Alitretinoin—Hepatitis—Esomeprazole—Barrett's esophagus	0.000927	0.00207	CcSEcCtD
Alitretinoin—Hepatitis—Omeprazole—Barrett's esophagus	0.000927	0.00207	CcSEcCtD
Alitretinoin—RXRA—Biological oxidations—CYP26A1—Barrett's esophagus	0.000926	0.00362	CbGpPWpGaD
Alitretinoin—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000922	0.00206	CcSEcCtD
Alitretinoin—Hallucination—Esomeprazole—Barrett's esophagus	0.000922	0.00206	CcSEcCtD
Alitretinoin—Hallucination—Omeprazole—Barrett's esophagus	0.000922	0.00206	CcSEcCtD
Alitretinoin—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000922	0.00206	CcSEcCtD
Alitretinoin—Pharyngitis—Omeprazole—Barrett's esophagus	0.00092	0.00206	CcSEcCtD
Alitretinoin—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00092	0.00206	CcSEcCtD
Alitretinoin—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000916	0.00205	CcSEcCtD
Alitretinoin—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000916	0.00205	CcSEcCtD
Alitretinoin—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000913	0.00204	CcSEcCtD
Alitretinoin—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000913	0.00204	CcSEcCtD
Alitretinoin—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000909	0.00203	CcSEcCtD
Alitretinoin—Urethral disorder—Omeprazole—Barrett's esophagus	0.000909	0.00203	CcSEcCtD
Alitretinoin—Visual impairment—Omeprazole—Barrett's esophagus	0.000893	0.002	CcSEcCtD
Alitretinoin—Visual impairment—Esomeprazole—Barrett's esophagus	0.000893	0.002	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—BMP4—Barrett's esophagus	0.000878	0.00343	CbGpPWpGaD
Alitretinoin—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000877	0.00196	CcSEcCtD
Alitretinoin—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000877	0.00196	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000871	0.0034	CbGpPWpGaD
Alitretinoin—Eye disorder—Omeprazole—Barrett's esophagus	0.000866	0.00194	CcSEcCtD
Alitretinoin—Eye disorder—Esomeprazole—Barrett's esophagus	0.000866	0.00194	CcSEcCtD
Alitretinoin—Tinnitus—Esomeprazole—Barrett's esophagus	0.000864	0.00193	CcSEcCtD
Alitretinoin—Tinnitus—Omeprazole—Barrett's esophagus	0.000864	0.00193	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000864	0.00337	CbGpPWpGaD
Alitretinoin—Flushing—Esomeprazole—Barrett's esophagus	0.00086	0.00192	CcSEcCtD
Alitretinoin—Flushing—Omeprazole—Barrett's esophagus	0.00086	0.00192	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000847	0.00331	CbGpPWpGaD
Alitretinoin—Chills—Esomeprazole—Barrett's esophagus	0.000832	0.00186	CcSEcCtD
Alitretinoin—Chills—Omeprazole—Barrett's esophagus	0.000832	0.00186	CcSEcCtD
Alitretinoin—Alopecia—Esomeprazole—Barrett's esophagus	0.000819	0.00183	CcSEcCtD
Alitretinoin—Alopecia—Omeprazole—Barrett's esophagus	0.000819	0.00183	CcSEcCtD
Alitretinoin—Mental disorder—Esomeprazole—Barrett's esophagus	0.000812	0.00182	CcSEcCtD
Alitretinoin—Mental disorder—Omeprazole—Barrett's esophagus	0.000812	0.00182	CcSEcCtD
Alitretinoin—RXRB—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000812	0.00317	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000812	0.00317	CbGpPWpGaD
Alitretinoin—Malnutrition—Omeprazole—Barrett's esophagus	0.000807	0.00181	CcSEcCtD
Alitretinoin—Malnutrition—Esomeprazole—Barrett's esophagus	0.000807	0.00181	CcSEcCtD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000806	0.00315	CbGpPWpGaD
Alitretinoin—Flatulence—Esomeprazole—Barrett's esophagus	0.000795	0.00178	CcSEcCtD
Alitretinoin—Flatulence—Omeprazole—Barrett's esophagus	0.000795	0.00178	CcSEcCtD
Alitretinoin—Tension—Omeprazole—Barrett's esophagus	0.000792	0.00177	CcSEcCtD
Alitretinoin—Tension—Esomeprazole—Barrett's esophagus	0.000792	0.00177	CcSEcCtD
Alitretinoin—Nervousness—Esomeprazole—Barrett's esophagus	0.000784	0.00175	CcSEcCtD
Alitretinoin—Nervousness—Omeprazole—Barrett's esophagus	0.000784	0.00175	CcSEcCtD
Alitretinoin—Back pain—Omeprazole—Barrett's esophagus	0.000781	0.00175	CcSEcCtD
Alitretinoin—Back pain—Esomeprazole—Barrett's esophagus	0.000781	0.00175	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—PPARG—Barrett's esophagus	0.000778	0.00304	CbGpPWpGaD
Alitretinoin—Vision blurred—Omeprazole—Barrett's esophagus	0.000761	0.0017	CcSEcCtD
Alitretinoin—Vision blurred—Esomeprazole—Barrett's esophagus	0.000761	0.0017	CcSEcCtD
Alitretinoin—Tremor—Omeprazole—Barrett's esophagus	0.000756	0.00169	CcSEcCtD
Alitretinoin—Tremor—Esomeprazole—Barrett's esophagus	0.000756	0.00169	CcSEcCtD
Alitretinoin—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000749	0.00167	CcSEcCtD
Alitretinoin—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000749	0.00167	CcSEcCtD
Alitretinoin—Anaemia—Esomeprazole—Barrett's esophagus	0.000746	0.00167	CcSEcCtD
Alitretinoin—Anaemia—Omeprazole—Barrett's esophagus	0.000746	0.00167	CcSEcCtD
Alitretinoin—Agitation—Omeprazole—Barrett's esophagus	0.000742	0.00166	CcSEcCtD
Alitretinoin—Agitation—Esomeprazole—Barrett's esophagus	0.000742	0.00166	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—PPARG—Barrett's esophagus	0.000732	0.00286	CbGpPWpGaD
Alitretinoin—Malaise—Esomeprazole—Barrett's esophagus	0.000728	0.00163	CcSEcCtD
Alitretinoin—Malaise—Omeprazole—Barrett's esophagus	0.000728	0.00163	CcSEcCtD
Alitretinoin—Palpitations—Esomeprazole—Barrett's esophagus	0.000713	0.0016	CcSEcCtD
Alitretinoin—Palpitations—Omeprazole—Barrett's esophagus	0.000713	0.0016	CcSEcCtD
Alitretinoin—Cough—Esomeprazole—Barrett's esophagus	0.000704	0.00158	CcSEcCtD
Alitretinoin—Cough—Omeprazole—Barrett's esophagus	0.000704	0.00158	CcSEcCtD
Alitretinoin—Hypertension—Esomeprazole—Barrett's esophagus	0.000697	0.00156	CcSEcCtD
Alitretinoin—Hypertension—Omeprazole—Barrett's esophagus	0.000697	0.00156	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—PTGES—Barrett's esophagus	0.000691	0.0027	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGES—Barrett's esophagus	0.000691	0.0027	CbGpPWpGaD
Alitretinoin—Chest pain—Esomeprazole—Barrett's esophagus	0.000687	0.00154	CcSEcCtD
Alitretinoin—Myalgia—Omeprazole—Barrett's esophagus	0.000687	0.00154	CcSEcCtD
Alitretinoin—Chest pain—Omeprazole—Barrett's esophagus	0.000687	0.00154	CcSEcCtD
Alitretinoin—Arthralgia—Omeprazole—Barrett's esophagus	0.000687	0.00154	CcSEcCtD
Alitretinoin—Arthralgia—Esomeprazole—Barrett's esophagus	0.000687	0.00154	CcSEcCtD
Alitretinoin—Myalgia—Esomeprazole—Barrett's esophagus	0.000687	0.00154	CcSEcCtD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000686	0.00268	CbGpPWpGaD
Alitretinoin—Anxiety—Omeprazole—Barrett's esophagus	0.000685	0.00153	CcSEcCtD
Alitretinoin—Anxiety—Esomeprazole—Barrett's esophagus	0.000685	0.00153	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000682	0.00153	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000682	0.00153	CcSEcCtD
Alitretinoin—Discomfort—Esomeprazole—Barrett's esophagus	0.000679	0.00152	CcSEcCtD
Alitretinoin—Discomfort—Omeprazole—Barrett's esophagus	0.000679	0.00152	CcSEcCtD
Alitretinoin—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000677	0.00265	CbGpPWpGaD
Alitretinoin—Dry mouth—Omeprazole—Barrett's esophagus	0.000672	0.0015	CcSEcCtD
Alitretinoin—Dry mouth—Esomeprazole—Barrett's esophagus	0.000672	0.0015	CcSEcCtD
Alitretinoin—Confusional state—Omeprazole—Barrett's esophagus	0.000664	0.00149	CcSEcCtD
Alitretinoin—Confusional state—Esomeprazole—Barrett's esophagus	0.000664	0.00149	CcSEcCtD
Alitretinoin—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000659	0.00147	CcSEcCtD
Alitretinoin—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000659	0.00147	CcSEcCtD
Alitretinoin—Infection—Esomeprazole—Barrett's esophagus	0.000654	0.00146	CcSEcCtD
Alitretinoin—Infection—Omeprazole—Barrett's esophagus	0.000654	0.00146	CcSEcCtD
Alitretinoin—Shock—Esomeprazole—Barrett's esophagus	0.000648	0.00145	CcSEcCtD
Alitretinoin—Shock—Omeprazole—Barrett's esophagus	0.000648	0.00145	CcSEcCtD
Alitretinoin—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000646	0.00144	CcSEcCtD
Alitretinoin—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000646	0.00144	CcSEcCtD
Alitretinoin—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000645	0.00144	CcSEcCtD
Alitretinoin—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000645	0.00144	CcSEcCtD
Alitretinoin—Tachycardia—Omeprazole—Barrett's esophagus	0.000643	0.00144	CcSEcCtD
Alitretinoin—Tachycardia—Esomeprazole—Barrett's esophagus	0.000643	0.00144	CcSEcCtD
Alitretinoin—Skin disorder—Omeprazole—Barrett's esophagus	0.00064	0.00143	CcSEcCtD
Alitretinoin—Skin disorder—Esomeprazole—Barrett's esophagus	0.00064	0.00143	CcSEcCtD
Alitretinoin—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000637	0.00142	CcSEcCtD
Alitretinoin—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000637	0.00142	CcSEcCtD
Alitretinoin—Anorexia—Esomeprazole—Barrett's esophagus	0.000628	0.0014	CcSEcCtD
Alitretinoin—Anorexia—Omeprazole—Barrett's esophagus	0.000628	0.0014	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.0006	0.00134	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.0006	0.00134	CcSEcCtD
Alitretinoin—Insomnia—Omeprazole—Barrett's esophagus	0.000596	0.00133	CcSEcCtD
Alitretinoin—Insomnia—Esomeprazole—Barrett's esophagus	0.000596	0.00133	CcSEcCtD
Alitretinoin—Paraesthesia—Omeprazole—Barrett's esophagus	0.000591	0.00132	CcSEcCtD
Alitretinoin—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000591	0.00132	CcSEcCtD
Alitretinoin—Dyspnoea—Omeprazole—Barrett's esophagus	0.000587	0.00131	CcSEcCtD
Alitretinoin—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000587	0.00131	CcSEcCtD
Alitretinoin—Somnolence—Esomeprazole—Barrett's esophagus	0.000586	0.00131	CcSEcCtD
Alitretinoin—Somnolence—Omeprazole—Barrett's esophagus	0.000586	0.00131	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000581	0.00227	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—Barrett's esophagus	0.00058	0.00227	CbGpPWpGaD
Alitretinoin—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00058	0.0013	CcSEcCtD
Alitretinoin—Dyspepsia—Omeprazole—Barrett's esophagus	0.00058	0.0013	CcSEcCtD
Alitretinoin—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000573	0.00128	CcSEcCtD
Alitretinoin—Decreased appetite—Omeprazole—Barrett's esophagus	0.000573	0.00128	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000569	0.00127	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000569	0.00127	CcSEcCtD
Alitretinoin—Fatigue—Esomeprazole—Barrett's esophagus	0.000568	0.00127	CcSEcCtD
Alitretinoin—Fatigue—Omeprazole—Barrett's esophagus	0.000568	0.00127	CcSEcCtD
Alitretinoin—Constipation—Esomeprazole—Barrett's esophagus	0.000563	0.00126	CcSEcCtD
Alitretinoin—Pain—Omeprazole—Barrett's esophagus	0.000563	0.00126	CcSEcCtD
Alitretinoin—Constipation—Omeprazole—Barrett's esophagus	0.000563	0.00126	CcSEcCtD
Alitretinoin—Pain—Esomeprazole—Barrett's esophagus	0.000563	0.00126	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000557	0.00218	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000556	0.00217	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000543	0.00121	CcSEcCtD
Alitretinoin—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000543	0.00121	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000539	0.0012	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000539	0.0012	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—CYP26A1—Barrett's esophagus	0.000523	0.00205	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CYP26A1—Barrett's esophagus	0.000523	0.00205	CbGpPWpGaD
Alitretinoin—Urticaria—Esomeprazole—Barrett's esophagus	0.000523	0.00117	CcSEcCtD
Alitretinoin—Urticaria—Omeprazole—Barrett's esophagus	0.000523	0.00117	CcSEcCtD
Alitretinoin—Body temperature increased—Omeprazole—Barrett's esophagus	0.000521	0.00116	CcSEcCtD
Alitretinoin—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000521	0.00116	CcSEcCtD
Alitretinoin—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000521	0.00116	CcSEcCtD
Alitretinoin—Abdominal pain—Omeprazole—Barrett's esophagus	0.000521	0.00116	CcSEcCtD
Alitretinoin—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000485	0.00109	CcSEcCtD
Alitretinoin—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000485	0.00109	CcSEcCtD
Alitretinoin—RXRA—NRF2 pathway—HGF—Barrett's esophagus	0.000485	0.0019	CbGpPWpGaD
Alitretinoin—Asthenia—Esomeprazole—Barrett's esophagus	0.000473	0.00106	CcSEcCtD
Alitretinoin—Asthenia—Omeprazole—Barrett's esophagus	0.000473	0.00106	CcSEcCtD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—RELA—Barrett's esophagus	0.000469	0.00183	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000469	0.00183	CbGpPWpGaD
Alitretinoin—Pruritus—Omeprazole—Barrett's esophagus	0.000466	0.00104	CcSEcCtD
Alitretinoin—Pruritus—Esomeprazole—Barrett's esophagus	0.000466	0.00104	CcSEcCtD
Alitretinoin—RARG—Gene Expression—NR1I2—Barrett's esophagus	0.000455	0.00178	CbGpPWpGaD
Alitretinoin—Diarrhoea—Omeprazole—Barrett's esophagus	0.000451	0.00101	CcSEcCtD
Alitretinoin—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000451	0.00101	CcSEcCtD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000446	0.00174	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000441	0.00172	CbGpPWpGaD
Alitretinoin—RXRA—PPARA activates gene expression—PPARG—Barrett's esophagus	0.000436	0.0017	CbGpPWpGaD
Alitretinoin—Dizziness—Omeprazole—Barrett's esophagus	0.000436	0.000974	CcSEcCtD
Alitretinoin—Dizziness—Esomeprazole—Barrett's esophagus	0.000436	0.000974	CcSEcCtD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.000427	0.00167	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000423	0.00165	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000423	0.00165	CbGpPWpGaD
Alitretinoin—Vomiting—Omeprazole—Barrett's esophagus	0.000419	0.000937	CcSEcCtD
Alitretinoin—Vomiting—Esomeprazole—Barrett's esophagus	0.000419	0.000937	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—NR1I2—Barrett's esophagus	0.000416	0.00162	CbGpPWpGaD
Alitretinoin—Rash—Omeprazole—Barrett's esophagus	0.000415	0.000929	CcSEcCtD
Alitretinoin—Rash—Esomeprazole—Barrett's esophagus	0.000415	0.000929	CcSEcCtD
Alitretinoin—Dermatitis—Esomeprazole—Barrett's esophagus	0.000415	0.000928	CcSEcCtD
Alitretinoin—Dermatitis—Omeprazole—Barrett's esophagus	0.000415	0.000928	CcSEcCtD
Alitretinoin—Headache—Omeprazole—Barrett's esophagus	0.000413	0.000923	CcSEcCtD
Alitretinoin—Headache—Esomeprazole—Barrett's esophagus	0.000413	0.000923	CcSEcCtD
Alitretinoin—RARB—Gene Expression—NR1I2—Barrett's esophagus	0.000408	0.00159	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000398	0.00155	CbGpPWpGaD
Alitretinoin—Nausea—Omeprazole—Barrett's esophagus	0.000391	0.000875	CcSEcCtD
Alitretinoin—Nausea—Esomeprazole—Barrett's esophagus	0.000391	0.000875	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—NR1I2—Barrett's esophagus	0.000391	0.00153	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NR1I2—Barrett's esophagus	0.000391	0.00153	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000387	0.00151	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000387	0.00151	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—PPARG—Barrett's esophagus	0.000381	0.00149	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—SLC9A1—Barrett's esophagus	0.000377	0.00147	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—SLC9A1—Barrett's esophagus	0.000377	0.00147	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000356	0.00139	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000311	0.00121	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000304	0.00119	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000304	0.00119	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.000296	0.00115	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.000294	0.00115	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000292	0.00114	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.00029	0.00114	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000284	0.00111	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000279	0.00109	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000267	0.00104	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000267	0.00104	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000263	0.00103	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000252	0.000984	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000244	0.000953	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000226	0.000884	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000221	0.000862	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.00022	0.000859	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGES—Barrett's esophagus	0.000209	0.000817	CbGpPWpGaD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000206	0.000803	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NR1I2—Barrett's esophagus	0.000204	0.000796	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000173	0.000677	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PPARG—Barrett's esophagus	0.000172	0.000673	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PPARG—Barrett's esophagus	0.000172	0.000673	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000159	0.000621	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP26A1—Barrett's esophagus	0.000158	0.000619	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00015	0.000585	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—PPARG—Barrett's esophagus	0.00015	0.000585	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000139	0.000544	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—PPARG—Barrett's esophagus	0.000137	0.000535	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—Barrett's esophagus	0.000135	0.000529	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—Barrett's esophagus	0.000135	0.000529	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARG—Barrett's esophagus	0.000134	0.000524	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000131	0.000513	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARG—Barrett's esophagus	0.000131	0.000512	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARG—Barrett's esophagus	0.000129	0.000503	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARG—Barrett's esophagus	0.000129	0.000503	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000117	0.000457	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000116	0.000454	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SLC9A1—Barrett's esophagus	0.000114	0.000446	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—RELA—Barrett's esophagus	0.000106	0.000415	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	9.75e-05	0.000381	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	9.21e-05	0.00036	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	8.81e-05	0.000344	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGES—Barrett's esophagus	8.36e-05	0.000326	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—Barrett's esophagus	6.71e-05	0.000262	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGES—Barrett's esophagus	6.67e-05	0.000261	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	6.33e-05	0.000247	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	5.25e-05	0.000205	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—Barrett's esophagus	5.21e-05	0.000204	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	5.05e-05	0.000198	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	4.56e-05	0.000178	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—Barrett's esophagus	4.1e-05	0.00016	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.73e-05	0.000146	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	3.64e-05	0.000142	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.94e-05	0.000115	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—Barrett's esophagus	2.08e-05	8.14e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—Barrett's esophagus	1.66e-05	6.5e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.64e-05	6.4e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	1.31e-05	5.11e-05	CbGpPWpGaD
